Evidence map›Paper›PMID 25983217›Full record

ArticleScientific reports2015

High-Throughput Microfluidic Platform for 3D Cultures of Mesenchymal Stem Cells, Towards Engineering Developmental Processes.

Paola Occhetta, Matteo Centola, Beatrice Tonnarelli, Alberto Redaelli, Ivan Martin, Marco Rasponi

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed
9.1field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 85 citations in OpenAlex.

  1. Article
  2. Article
  3. Microfluidic Systems for Neural Cell Studies.Bioengineering (Basel, Switzerland) · 2023
    Review
  4. Review
  5. Review
  6. Review
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Stem cells technology: a powerful tool behind new brain treatments.Drug delivery and translational research · 2018
    Review
  15. Article
  16. Developmentally inspired programming of adult human mesenchymal stromal cells toward stable chondrogenesis.Proceedings of the National Academy of Sciences of the United States of America · 2018
    Article
  17. Article
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Paola Occhetta1] Department of Electronics, Information and Bioengineering, Politecnico di Milano, Milano, Italy [2] Departments of Surgery and of Biomedicine, University Hospital Basel, University of Basel, Basel, Switzerland.
Matteo CentolaDepartments of Surgery and of Biomedicine, University Hospital Basel, University of Basel, Basel, Switzerland.
Beatrice TonnarelliDepartments of Surgery and of Biomedicine, University Hospital Basel, University of Basel, Basel, Switzerland.
Alberto RedaelliDepartment of Electronics, Information and Bioengineering, Politecnico di Milano, Milano, Italy.
Ivan MartinDepartments of Surgery and of Biomedicine, University Hospital Basel, University of Basel, Basel, Switzerland.
Marco RasponiDepartment of Electronics, Information and Bioengineering, Politecnico di Milano, Milano, Italy.
Politecnico di Milano · ITUniversity of Basel · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The development of in vitro models to screen the effect of different concentrations, combinations and temporal sequences of morpho-regulatory factors on stem/progenitor cells is crucial to investigate and possibly recapitulate developmental processes with adult cells. Here, we designed and validated a microfluidic platform to (i) allow cellular condensation, (ii) culture 3D micromasses of human bone marrow-derived mesenchymal stromal cells (hBM-MSCs) under continuous flow perfusion, and (ii) deliver defined concentrations of morphogens to specific culture units. Condensation of hBM-MSCs was obtained within 3 hours, generating micromasses in uniform sizes (56.2 ± 3.9 μm). As compared to traditional macromass pellet cultures, exposure to morphogens involved in the first phases of embryonic limb development (i.e. Wnt and FGF pathways) yielded more uniform cell response throughout the 3D structures of perfused micromasses (PMMs), and a 34-fold higher percentage of proliferating cells at day 7. The use of a logarithmic serial dilution generator allowed to identify an unexpected concentration of TGFβ3 (0.1 ng/ml) permissive to hBM-MSCs proliferation and inductive to chondrogenesis. This proof-of-principle study supports the described microfluidic system as a tool to investigate processes involved in mesenchymal progenitor cells differentiation, towards a 'developmental engineering' approach for skeletal tissue regeneration.

Indexed as

Cell Culture TechniquesTissue EngineeringCell DifferentiationCell ProliferationCells, CulturedCollagen Type IIFibroblast Growth Factor 2HumansMesenchymal Stem CellsMicrofluidicsTransforming Growth Factor beta3Wnt3A ProteinCollagen Type IIFibroblast Growth Factor 2Transforming Growth Factor beta3Wnt3A Protein

Identifiers

PMID25983217
PMCPMC4650750
OpenAlexW2252578797

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.